Biotech Investors & VC Firms
2483 firms in this list, with a median first check of $500K. 508 of them lead rounds. Generated from verified public data and updated continuously.
PONTIS
ViennaSeed–Growth
2 people
East Gate Partners
SeoulSeed–Series A
2 people
Global Venture Capital, Inc.
TokyoSeed–Series A
2 people
Lime Street Ventures
BostonPre-Seed–Seed
2 people
Malaysia Debt Ventures Bhd.
Kuala LumpurSeed–Late Stage
2 people
ShangPharma Innovation
South San FranciscoSeed–Series A
2 people
Shenzhen Leaguer Tsing-Yuan Venture Capital Management Co., Ltd.
ShenzhenSeed–Series B
2 people
SilverArc Capital
Boston
2 people
Tohoku Innovation Capital Corporation
MiyagiSeed–Series A
2 people
Vesalius Ventures
HoustonSeed
2 people
Gabriel Investment Syndicate
Pre-Seed–Seed
1 person
Heritage Medical Systems
West HillsSeed
1 person
Science Creates Ventures
BristolPre-Seed–Seed
1 person
CDIB Capital
Hong KongSeries A–Series C
Innovation Ulster
NewtownabbeySeed–Series A
Healthequity
BarcelonaSeed–Late Stage
1 person
Orrick Herrington & Sutcliffe
1 person
IBK Capital
SeoulSeed–Series B
Quark Venture Inc.
VancouverSeed–Series C
Woodford Investment Management
OxfordSeries A–Growth
Bayside Biosciences, Inc.
Santa ClaraSeed
1 person
EISAI CO.,LTD
TokyoSeed–Growth
1 person
Genesis BioCapital
Chattanooga
1 person
Hermes-Epitek
HsinchuSeed
1 person
Related lists
Investors & VC Firms in North America (12857)Investors & VC Firms in United States (11900)Investors & VC Firms in Europe (5839)Investors & VC Firms in Global (4754)AI & Machine Learning Investors & VC Firms (4575)Fintech Investors & VC Firms (4551)SaaS Investors & VC Firms (4225)Healthtech Investors & VC Firms (4199)Enterprise Software Investors & VC Firms (4105)Crypto & Web3 Investors & VC Firms (3975)
Data sourced from public filings and firms' own websites — see our methodology.









